Blog Posts

Second Opinion: No, Big Pharma Is Not Changing

Jan 11, 2019

Right on cue, dozens of pharmaceutical companies rang in the new year by Read More

Second Opinion: Big Pharma’s Back At It

Dec 3, 2018

If at first you don’t succeed try, try again.  That’s the old adage Big Read More

It’s Time To Go To Work To Lower Prescription Drug Prices

Nov 12, 2018

Now that the midterms are over, it is now time for candidates to do what they Read More

On Message: Big Pharma Executives Double Down On Monopolistic Business Strategy

Nov 6, 2018

Executives of three major drug manufacturers – Pfizer, Merck and AbbVie – Read More

Voters want solutions to out-of-control drug prices

Nov 2, 2018

The American economy may be booming and paychecks may be growing Read More

SECOND OPINION: Don’t Be Fooled.  Drug Companies Are Responsible For High Drug Prices

Oct 23, 2018

Repeating the same false claim over and over again doesn’t make it true.  Read More

Second Opinion: The Truth About The Big Pharma Bailout

Sep 25, 2018

In their latest attempt to make billions of dollars on the backs of patients, Read More

Stop Big Pharma’s $4 Billion Bailout

Sep 21, 2018

As the country is hoping for lower drug prices, more affordable care Read More

SECOND OPINION: Big Pharma Continues Pointing Fingers for Excessive Drug Prices

Sep 12, 2018

Apparently, when it comes to out-of-control drug prices, everyone’s to blame Read More

Second Opinion: The Real Source of Rising Drug Prices

Sep 10, 2018

Big Pharma is always eager to play the blame game – attempting to divert Read More

Campaign Launches Nationwide Effort to Highlight Voter Concerns Over Rising Prescription Drug Prices

Jul 11, 2016

“Voters across the country are calling for action by their elected officials to make sure patients and families don’t have to choose between filling a prescription and putting food on the table,” said CSRxP Executive Director John Rother. “The trend of rising drug prices needs to be addressed, and we expect voters will take that message – and a call for solutions – to candidates at all levels this fall.” Read More

Rising Prescription Drug Prices: Can We Keep Up?

May 19, 2016

We need to move toward market-based solutions to increase transparency, promote competition, and enhance value. For the millions of Americans living with chronic conditions - including allergies and arthritis, these solutions cannot come soon enough. Read More